| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |